Suven Life shares gain 4.5% as its facility completes USFDA inspection
Team Udayavani, May 7, 2018, 5:57 PM IST
New Delhi: Shares of Suven Life Sciences today rose by 4.5 per cent after the company said its Pashamylaram facility near Hyderabad has undergone successful inspection by the US health regulator.
The stock jumped 4.55 per cent to close at Rs 189.50 on BSE. Intra-day, it gained 5.93 per cent to Rs 192.
At NSE, shares of the company rose by 4.54 per cent to close at Rs 189.75.
In terms of equity volume, 1.61 lakh shares of the company were traded on BSE and over 11 lakh shares changed hands at NSE during the day.
The facility has undergone renewal inspection from February 5-18 by the United States Food and Drug Administration (USFDA), Suven Life Sciences said in a BSE filing.
The plant is considered to be in an acceptable state of compliance with regards to current good manufacturing practices (CGMP) and the agency has issued an Establishment Inspection Report (EIR) for the facility, it added.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Maharashtra: Jewellers face challenges in business as wedding season clashes with poll season
Maharashtra Elections | CM Shinde using Marathi TV serials for campaigning, Congress alleges
Misuse of social media platforms by terrorists to be borne in mind by courts while sentencing: HC
Forest department creating hurdles in development of Gadchiroli district: Gadkari
Ensure level playing field in campaigning: Congress to EC after Rahul’s chopper delay
MUST WATCH
Latest Additions
Siddaramaiah will resign as CM before Belagavi assembly session, claims BJP’s Vijayendra
Mangaluru: 3 key suspects in cyber fraud cases arrested
Yakshadhruva Patla Foundation women’s wing launched in Udupi
Champions Trophy: ICC puts PCB’s ‘PoK’ tour on hold after BCCI’s strong objection
Maharashtra: Jewellers face challenges in business as wedding season clashes with poll season
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.